REHOVOT, Israel, Feb. 14, 2017 /PRNewswire/ -- Nova Measuring Instruments (Nasdaq: NVMI), a leading innovator and a key provider of metrology solutions for advanced process control used in semiconductor manufacturing, today reported record financial results for the fourth quarter and full year 2016, the periods ended December 31, 2016.

Fourth Quarter 2016 Highlights:


    --  Record quarterly revenue of $50.2 million, up 14% sequentially and 25%
        year-over-year, significantly exceeding guidance of $42 to $46 million
        and as preannounced on January 26, 2017
    --  GAAP net income of $8.4 million, or $0.30 per diluted share, up 58%
        year-over-year on a per-share basis, exceeding guidance of $0.23 to
        $0.29 per share
    --  Non-GAAP net income of $11.7 million, or $0.42 per diluted share, up 24%
        sequentially and 121% year-over-year on a per-share basis, exceeding
        guidance of $0.31 to $0.40 per share
    --  Received over $10 million in XPS orders from multiple foundry customers
    --  Received multiple orders from leading 3D-NAND manufacturers

Full Year 2016 Highlights:


    --  Record full-year revenue of $163.9 million, up 10% year-over-year
    --  GAAP net income of $9.6 million, or $0.35 per diluted share, including
        non-recurring expense of $12.9 million related to royalty payment to the
        Israeli Office of the Chief Scientist
    --  Record non-GAAP net income of $30.3 million, or $1.10 per diluted share,
        up 44% year-over-year on a per-share basis
    --  Diversified customer mix yielded four customers contributing more than
        10% each to the annual product revenues


    GAAP Results ($K)
    ----------------

                                      Q4 2016         Q3 2016          Q4 2015         FY 2016         FY 2015
                                      -------         -------          -------         -------         -------

    Revenues                                  $50,212          $44,060         $40,022         $163,903        $148,514
    --------                                  -------          -------         -------         --------        --------

    Net Income (Loss)                          $8,364         $(4,778)         $5,161           $9,644         $15,725
    ----------------                           ------          -------          ------           ------         -------

    Earnings (Loss) per Diluted Share           $0.30          $(0.18)          $0.19            $0.35           $0.57
    ---------------------------------           -----           ------           -----            -----           -----

    NON-GAAP Results ($K)
    --------------------

                                      Q4 2016         Q3 2016          Q4 2015         FY 2016         FY 2015
                                      -------         -------          -------         -------         -------

    Net Income                                $11,719           $9,449          $5,278          $30,321         $21,030
    ----------                                -------           ------          ------          -------         -------

    Earnings per Diluted Share                  $0.42            $0.34           $0.19            $1.10           $0.76
    --------------------------                  -----            -----           -----            -----           -----

A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements that are part of this release. Non-GAAP results exclude amortization of acquired intangible assets, net adjustments of deferred tax assets, stock-based compensation expenses, acquisition related expenses, expense related to royalty buyout agreement with the Office of the Chief Scientist and inventory write-off.

Management Comments

"The fourth quarter was an outstanding conclusion to another record year, demonstrating our ability to execute our growth plans effectively while improving our customer diversification and operational model," commented Eitan Oppenhaim, President and Chief Executive Officer of Nova. "We believe that the strong end to 2016 sets us on course for another growth year in 2017, bolstered by growing demand for our entire product portfolio, combining dimensions and materials metrology solutions. The strength of our business, as evidenced by our strong guidance for the first quarter, will continue into 2017 as we continue to secure wins from multiple customers in various industry segments."

Mr. Oppenhaim continued, "Nova's broad offering, which is embraced by our diversified customer base, allows us today to address a wider range of challenges that generate more opportunities for us to grow in 2017. During our continued growth, we have leveraged our proven business model to drive record profits, as evidenced by the significant increase in full-year non-GAAP net income. We expect to continue to benefit from our efficient business model in the coming years, leading to continued profitable growth."

2017 First Quarter Financial Outlook

Management provided an outlook for the first quarter, the period ending March 31, 2017. Based on current estimates, management expects:


    --  $50 million to $54 million in revenue
    --  $0.31 to $0.39 in diluted GAAP EPS
    --  $0.37 to $0.45 in diluted non-GAAP EPS

2016 Fourth Quarter Results

Total revenues for the fourth quarter of 2016 were $50.2 million, in line with the results announced on January 26, 2017. Sequentially, this represented an increase of 14% compared to the third quarter of 2016, and an increase of 25% relative to the fourth quarter of 2015.

Gross margin for the fourth quarter of 2016 was 56%, compared sequentially with gross margin of 22% in the third quarter of 2016 (which included a non-recurring expense related to royalty buyout agreement) and compared with gross margin of 52% in the fourth quarter of 2015.

Operating expenses in the fourth quarter of 2016 were $17.4 million. This is compared with $16.6 million in the third quarter of 2016 and compared with $17.3 million in the fourth quarter of 2015.

On a GAAP basis, the company reported net income of $8.4 million, or $0.30 per diluted share, in the fourth quarter of 2016. This is compared with a net loss of $4.8 million, or $0.18 per diluted share, in the third quarter of 2016. The company reported net income of $5.2 million, or $0.19 per diluted share, in the fourth quarter of 2015.

On a non-GAAP basis, which excludes amortization of acquired intangible assets, net adjustments of deferred tax assets and stock-based compensation expenses, the company reported net income of $11.7 million, or $0.42 per diluted share, in the fourth quarter of 2016. This is compared with net income of $9.4 million, or $0.34 per diluted share, in the third quarter of 2016, and compared with net income of $5.3 million, or $0.19 per diluted share, in the fourth quarter of 2015.

Cash utilization in the fourth quarter was higher than normal mainly due to the timing of shipments during the quarter, and management expects the first quarter of 2017 to include higher than normal cash generation.

2016 Full Year Results

Total revenues for 2016 were $163.9 million, an increase of 10% compared to total revenues of $148.5 million for 2015.

Gross margin in 2016 was 46%, and included $12.9 million of non-recurring expense related to royalty buyout agreement. This is compared with gross margin of 52% in 2015.

Operating expenses in 2016 were $65.1 million, compared with operating expenses of $65.5 million in 2015.

On a GAAP basis, which included $12.9 million of expense related to a royalty buyout agreement with the Office of the Chief Scientist, the company reported net income of $9.6 million, or $0.35 per diluted share, in 2016. This is compared with a net income of $15.7 million, or $0.57 per diluted share, in 2015.

On a non-GAAP basis, which excludes amortization of acquired intangible assets, net adjustments of deferred tax assets, stock-based compensation expenses, expense related to a royalty buyout agreement with the Office of the Chief Scientist and inventory write-off, the company reported net income of $30.3 million, or $1.10 per diluted share, in 2016. This is compared with net income of $21.0 million, or $0.76 per diluted share, in 2015.

Total cash reserves at the end of 2016 were $91.7 million, compared to $97.8 million at the end of 2015.

Conference Call Information

Nova will host a conference call today, February 14, 2017, at 9 a.m. Eastern Time, to discuss the financial results and future outlook. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your calls five minutes before the conference call commences. If you are unable to connect using the toll-free numbers, please try the international dial-in number.

U.S. Dial-in Number: 1-888-244-2417
ISRAEL Dial-in Number: 1 80 925 8350
INTERNATIONAL Dial-in Number: 1-913-312-0966
At:
9 a.m. Eastern Time
6 a.m. Pacific Time
4 p.m. Israeli Time

Please reference conference ID 3628025

The conference call will also be webcast live from a link on Nova's website at http://ir.novameasuring.com. For those unable to participate in the conference call, there will be a replay available from a link on Nova's website at http://ir.novameasuring.com.

About Nova: Nova Measuring Instruments delivers continuous innovation by providing advanced metrology solutions for the semiconductor manufacturing industry. Deployed with the world's largest integrated-circuit manufacturers, Nova's products deliver state-of-the-art, high-performance metrology solutions for effective process control throughout the semiconductor fabrication lifecycle. Nova's product portfolio, which combines high-precision hardware and cutting-edge software, supports the development and production of the most advanced devices in today's high-end semiconductor market. Nova's technical innovation and market leadership enable customers to improve process performance, enhance products' yields and accelerate time to market. Nova acts as a partner to semiconductor manufacturers from its offices around the world. Additional information may be found at www.novameasuring.com.

Nova is traded on the NASDAQ & TASE under the symbol NVMI.

This press release provides financial measures that exclude charges for amortization of acquired intangible assets, net adjustment of deferred tax assets, stock-based compensation expenses, acquisition related expenses, expense related to royalty buyout agreement with the Office of the Chief Scientist and inventory write-off and are therefore not calculated in accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding Nova's performance because they reflect our operational results and enhances management's and investors' ability to evaluate Nova's performance before charges or benefits considered by management to be outside Nova's ongoing operating results. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management believes that it is in the best interest of its investors to provide financial information that will facilitate comparison of both historical and future results and allows greater transparency to supplemental information used by management in its financial and operational decision making. A reconciliation of each GAAP to non-GAAP financial measure discussed in this press release is contained in the accompanying financial tables.

This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995 relating to future events or our future performance, such as statements regarding, but are not limited to, anticipated growth opportunities and projections about our business and its future revenues, expenses and profitability. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in those forward looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to, the following: our dependency on three product lines; our dependency on a small number of large customers and small number of suppliers; the highly cyclical and competitive nature of the markets we target and we operate in; our inability to reduce spending during a slowdown in the semiconductor industry; our ability to respond effectively on a timely basis to rapid technological changes; our ability to recognize the benefits of ReVera acquisition and risks that the acquisition may disrupt current plans and operations and impact relationships with customers, distributors and suppliers; our dependency on PEMs; risks related to exclusivity obligations and non-limited liability that may be included in our commercial agreements and arrangements; our ability to retain our competitive position despite the ongoing consolidation in our industry; risks related to our dependence on our manufacturing facilities; risks related to changes in our order backlog; risks related to the worldwide financial instabilities; risks related to our intellectual property; new product offerings from our competitors; unanticipated manufacturing or supply problems; risks related to government programs we participate in; risks related to taxation; changes in customer demand for our products; risks related to currency fluctuations, risks related to acquisitions we may pursue and risks related to our operations in Israel. We cannot guarantee future results, levels of activity, performance or achievements. The matters discussed in this press release also involve risks and uncertainties summarized under the heading "Risk Factors" in Nova's Annual Report on Form 20-F for the year ended December 31, 2015 filed with the Securities and Exchange Commission on February 29, 2016. These factors are updated from time to time through the filing of reports and registration statements with the Securities and Exchange Commission. Nova Measuring Instruments Ltd. does not assume any obligation to update the forward-looking information contained in this press release.


                         NOVA MEASURING INSTRUMENTS LTD.
                         -------------------------------

                      CONDENSED CONSOLIDATED BALANCE SHEETS
                      -------------------------------------

                    (U.S. dollars in thousands) -(Unaudited)


                                                             As of  December 31,
                                                             -------------------

    ASSETS                                                      2016           2015
                                                                ----           ----

    Current
     assets

    Cash and
     cash
     equivalents                                              20,406         27,733

    Short-term
     interest-
     bearing
     bank
     deposits                                                 70,546         69,298

    Trade
     accounts
     receivable                                               42,626         19,046

    Inventories                                               29,260         27,683

    Deferred tax
     assets                                                        -         3,540

    Other
     current
     assets                                                    5,068          2,888
                                                               -----          -----


    Total
     current
     assets                                                  167,906        150,188
                                                             -------        -------


    Long-term
     assets

    Long-term
     interest-
     bearing
     bank
     deposits                                                    750            750

       Deferred tax
        assets                                                 3,020          5,735

       Severance
        pay funds                                              1,425          1,514

       Property and
        equipment,
        net                                                   10,017         11,062

       Identifiable
        intangible
        assets, net                                           15,361         17,906

       Goodwill                                               20,114         20,114
                                                              ------         ------


    Total long-
     term assets                                              50,687         57,081
                                                              ------         ------


    Total assets                                             218,593        207,269
                                                             =======        =======


      LIABILITIES
      AND
      SHAREHOLDERS'
      EQUITY

    Current
     liabilities

    Trade
     accounts
     payable                                                  16,501         14,378

       Deferred
        revenues                                               4,072          5,828

       Deferred tax
        liabilities                                                -           956

       Other
        current
        liabilities                                           18,461         15,996
                                                              ------         ------


    Total
     current
     liabilities                                              39,034         37,158
                                                              ------         ------


    Long-term
     liabilities

       Deferred tax
        liabilities                                            1,094          5,760

       Liability
        for
        employee
        severance
        pay                                                    2,418          2,469

       Other long-
        term
        liabilities                                            1,330            822
                                                               -----            ---


    Total long-
     term
     liabilities                                               4,842          9,051
                                                               -----          -----


     Shareholders'
     equity                                                  174,717        161,060
                                                             -------        -------


    Total
     liabilities
     and
     shareholders'
     equity                                                  218,593        207,269
                                                             =======        =======



                                                                NOVA MEASURING INSTRUMENTS LTD.
                                                                -------------------------------

                                                        CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                                        -----------------------------------------------

                                                (U.S. dollars in thousands, except per share data) - (Unaudited)



                                                   Three months ended                      Year ended

                                                       December 31,                       December 31,
                                                       ------------                       ------------

                                                        2016                       2015                     2016             2015
                                                        ----                       ----                     ----             ----


    Revenues:

    Products                                          39,806                     30,581                  122,439          111,178

    Services                                          10,406                      9,441                   41,464           37,336
                                                      ------                      -----                   ------           ------

    Total revenues                                    50,212                     40,022                  163,903          148,514
                                                      ------                     ------                  -------          -------


    Cost of revenues:

    Products                                          15,497                     12,593                   48,577           47,185

    Services                                           6,557                      5,524                   25,282           20,743

       Expense related to
        royalty buyout
        agreement                                                     -                        -                 12,875                -

           with the Office of the
            Chief Scientist

    Inventory write-off                                               -                        -                  1,889                -

       Amortization of
        acquired intangible
        assets in                                                     -                    1,051                       -           3,506
                                                                    ---                    -----                     ---           -----

           cost of products

    Total cost of revenues                            22,054                     19,168                   88,623           71,434
                                                      ------                     ------                   ------           ------


    Gross profit                                      28,158                     20,854                   75,280           77,080


    Operating expenses:

    Research and
     development expenses,
     net                                               9,225                     10,826                   34,998           39,703

    Sales and marketing
     expenses                                          5,814                      4,474                   20,736           15,768

    General and
     administration
     expenses                                          1,702                      1,606                    6,835            5,856

    Acquisition related
     expenses                                                         -                        -                      -           2,655

    Amortization of
     acquired intangible
     assets                                              636                        378                    2,545            1,517
                                                         ---                        ---                    -----            -----

    Total operating
     expenses                                         17,377                     17,284                   65,114           65,499
                                                      ------                     ------                   ------           ------


    Operating income                                  10,781                      3,570                   10,166           11,581

    Financing income, net                                190                        184                    1,216              643
                                                         ---                        ---                    -----              ---


    Income before tax on
     income                                           10,971                      3,754                   11,382           12,224


    Income tax expenses
     (benefit)                                         2,607                    (1,407)                   1,738          (3,501)
                                                       -----                     ------                    -----           ------


    Net income for the
     period                                            8,364                      5,161                    9,644           15,725
                                                       =====                      =====                    =====           ======


    Earnings per share:

    Basic                                               0.31                       0.19                     0.35             0.58
                                                        ====                       ====                     ====             ====

    Diluted                                             0.30                       0.19                     0.35             0.57
                                                        ====                       ====                     ====             ====


    Shares used for calculation of earnings per
     share:


    Basic                                             27,292                     27,073                   27,175           27,185
                                                      ======                     ======                   ======           ======

    Diluted                                           27,704                     27,334                   27,503           27,510
                                                      ======                     ======                   ======           ======






                                                                 NOVA MEASURING INSTRUMENTS LTD.
                                                                 -------------------------------

                                                         CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                         -----------------------------------------------

                                                            (U.S. dollars in thousands) - (Unaudited)



                                                                                Three months ended                  Year ended

                                                                                   December 31,                    December 31,


                                                                               2016                           2015                  2016        2015
                                                                               ----                           ----                  ----        ----

    Cash flows from operating activities:

    Net income for the period                                                 8,364                          5,161                 9,644      15,725


    Adjustments to reconcile net income to net cash
    provided by (used in) operating activities:

    Depreciation                                                                731                          1,288                 4,271       4,597

    Amortization of acquired intangible assets                                  636                          1,429                 2,545       5,023

    Amortization of deferred stock-based compensation                           691                            765                 2,735       2,673

    Increase (decrease) in liability for employee                              (57)                            35                    38          70

      termination benefits, net

    Deferred tax assets, net                                                  2,028                        (2,077)                  633     (5,046)

    Loss on securities                                                            -                          (23)                    -       (10)

    Decrease (increase) in trade accounts receivable                       (19,068)                         4,297              (23,580)    (1,959)

    Decrease (increase) in inventories                                        (335)                           745               (1,670)    (1,949)

    Decrease (increase) in other current and long term                      (1,885)                           872               (2,180)        370

      assets

    Increase in trade accounts payable                                        4,127                          1,469                 2,123       1,604

    Increase in other current liabilities and                                 3,601                            683                 3,037       3,329

      other long-term liabilities

    Increase (decrease) in short and long term deferred                       (351)                       (1,928)              (1,756)      1,361

      revenues



    Net cash provided by (used in) operating activities                     (1,518)                        12,716               (4,160)     25,788
                                                                             ------                         ------                ------      ------


    Cash flow from investment activities:

    Decrease (increase) in short-term interest-bearing                        (998)                      (10,045)              (1,248)     37,991

      bank deposits

    Proceeds from short-term held for trading securities                          -                         2,005                     -      2,005

    Acquisition of subsidiary, net of acquired cash                               -                             -                    -   (45,344)

    Additions to property and equipment                                     (1,518)                       (2,205)              (3,133)    (4,373)
                                                                             ------                         ------                ------      ------


    Net cash used in investment activities                                  (2,516)                      (10,245)              (4,381)    (9,721)
                                                                             ------                        -------                ------      ------


    Cash flows from financing activities:

    Purchases of treasury shares                                                  -                             -                (937)    (4,302)

    Shares issued under employee stock-based plans                              786                            232                 2,151       2,319
                                                                                ---                            ---                 -----       -----


    Net cash provided by (used in) financing activities                         786                            232                 1,214     (1,983)
                                                                                ---                            ---                 -----      ------


    Increase (decrease) in cash and cash equivalents                        (3,248)                         2,703               (7,327)     14,084

    Cash and cash equivalents - beginning of period                          23,654                         25,030                27,733      13,649
                                                                             ------                         ------                ------      ------

    Cash and cash equivalents - end of period                                20,406                         27,733                20,406      27,733
                                                                             ======                         ======                ======      ======




                                                                               NOVA MEASURING INSTRUMENTS LTD.
                                                                               -------------------------------

                                                                         RECONCILIATION OF GAAP TO NON-GAAP RESULTS
                                                                         ------------------------------------------

                                                       (U.S. dollars in thousands, except percentage and per share data) - (Unaudited)



                                                         Three months ended
                                                         ------------------

                                                       December 31,                                         September  30,               December 31,
                                                                           2016                                                     2016                   2015
                                                                           ----                                                     ----                   ----

    GAAP cost of
     revenues                                                            22,054                                                   34,367                 19,168

      Amortization of
       acquired
       intangible assets
       in cost of
       products                                                               -                                                       -               (1,051)

      Expense related to
       royalty buyout
       agreement with the
       Office of the
       Chief Scientist                                                        -                                                (12,875)                     -

      Inventory write-
       off                                                                    -                                                 (1,889)                     -

      Stock-based
       compensation in
       cost of products                                                    (88)                                                    (79)                  (94)

      Stock-based
       compensation in
       cost of services                                                    (54)                                                    (52)                  (63)
                                                                            ---                                                      ---                    ---

    Non-GAAP cost of
     revenues                                                            21,912                                                   19,472                 17,960
                                                                         ======                                                   ======                 ======


    GAAP gross profit                                                    28,158                                                    9,693                 20,854

    Gross profit
     adjustments                                                            142                                                   14,895                  1,208
                                                                            ---                                                   ------                  -----

    Non-GAAP gross
     profit                                                              28,300                                                   24,588                 22,062
                                                                         ======                                                   ======                 ======

    GAAP gross margin as
     a percentage of
     revenues                                                               56%                                                     22%                   52%

    Non-GAAP gross
     margin as a
     percentage of
     revenues                                                               56%                                                     56%                   55%


    GAAP operating
     expenses                                                            17,377                                                   16,640                 17,284

      Stock-based
       compensation in
       research and
       development                                                        (247)                                                   (200)                 (322)

      Stock-based
       compensation in
       sales and
       marketing                                                          (211)                                                   (226)                 (213)

      Stock-based
       compensation in
       general and
       administrative                                                      (91)                                                    (82)                  (73)

      Amortization of
       acquired
       intangible assets                                                  (636)                                                   (637)                 (378)
                                                                           ----                                                     ----                   ----

    Non-GAAP operating
     expenses                                                            16,192                                                   15,495                 16,298
                                                                         ------                                                   ------                 ------

    Non-GAAP operating
     income                                                              12,108                                                    9,093                  5,764
                                                                         ======                                                    =====                  =====

    GAAP operating
     margin as a
     percentage of
     revenues                                                               21%                                                   (16%)                    9%

    Non-GAAP operating
     margin as a
     percentage of
     revenues                                                               24%                                                     21%                   14%


    GAAP tax on income                                                    2,607                                                  (1,868)               (1,407)

      Deferred tax assets
       adjustments, net                                                 (2,028)                                                   1,813                  2,077
                                                                         ------                                                    -----                  -----

    Non-GAAP tax on
     income                                                                 579                                                     (55)                   670
                                                                            ===                                                      ===                    ===


    GAAP net income
     (loss)                                                               8,364                                                  (4,778)                 5,161

      Amortization of
       acquired
       intangible assets                                                    636                                                      637                  1,429

      Expense related to
       royalty buyout
       agreement with the
       Office of   the
       Chief Scientist                                                        -                                                  12,875                      -

      Stock-based
       compensation
       expenses                                                             691                                                      639                    765

      Deferred tax assets
       adjustments, net                                                   2,028                                                  (1,813)               (2,077)

      Inventory write-
       off                                                                    -                                                   1,889                      -

    Non-GAAP net income                                                  11,719                                                    9,449                  5,278
                                                                         ======                                                    =====                  =====


    GAAP basic earnings
     (loss) per share                                                      0.31                                                   (0.18)                  0.19
                                                                           ====                                                    =====                   ====

    Non-GAAP basic
     earnings per share                                                    0.43                                                     0.35                   0.19
                                                                           ====                                                     ====                   ====


    GAAP diluted
     earnings (loss)
     per share                                                             0.30                                                   (0.18)                  0.19
                                                                           ====                                                    =====                   ====

    Non-GAAP diluted
     earnings per share                                                    0.42                                                     0.34                   0.19
                                                                           ====                                                     ====                   ====


    Shares used for calculation of earnings (loss) per
     share:

      Basic                                                              27,292                                                   27,169                 27,073
                                                                         ======                                                   ======                 ======

      Diluted                                                            27,704                                                   27,536                 27,334
                                                                         ======                                                   ======                 ======


                   NOVA MEASURING INSTRUMENTS LTD.
                   -------------------------------

             RECONCILIATION OF GAAP TO NON-GAAP RESULTS
             ------------------------------------------

    (U.S. dollars in thousands, except percentage and per share data) -
                             (Unaudited)



                                               Year ended December 31,
                                               -----------------------

                                                     2016                   2015
                                                     ----                   ----

    GAAP cost of
     revenues                                      88,623                 71,434

      Amortization of
       acquired
       intangible
       assets in cost
       of products                                      -               (3,506)

      Expense related
       to royalty
       buyout
       agreement with
       the Office of
       the Chief
       Scientist                                 (12,875)                     -

      Inventory
       write-off                                  (1,889)                     -

      Stock-based
       compensation
       in cost of
       products                                     (342)                 (373)

      Stock-based
       compensation
       in cost of
       services                                     (218)                 (203)
                                                     ----                   ----

    Non-GAAP cost
     of revenues                                   73,299                 67,352
                                                   ======                 ======


    GAAP gross
     profit                                        75,280                 77,080

    Gross profit
     adjustments                                   15,324                  4,082
                                                   ------                  -----

    Non-GAAP gross
     profit                                        90,604                 81,162
                                                   ======                 ======

    GAAP gross
     margin as a
     percentage of
     revenues                                         46%                   52%

    Non-GAAP gross
     margin as a
     percentage of
     revenues                                         55%                   55%


    GAAP operating
     expenses                                      65,114                 65,499

      Stock-based
       compensation
       in research
       and
       development                                  (983)               (1,084)

      Stock-based
       compensation
       in sales and
       marketing                                    (884)                 (744)

      Stock-based
       compensation
       in general and
       administrative                               (308)                 (269)

      Acquisition
       related
       expenses                                         -               (2,655)

      Amortization of
       acquired
       intangible
       assets                                     (2,545)               (1,517)
                                                   ------                 ------

    Non-GAAP
     operating
     expenses                                      60,394                 59,230
                                                   ------                 ------

    Non-GAAP
     operating
     income                                        30,210                 21,932
                                                   ======                 ======

    GAAP operating
     margin as a
     percentage of
     revenues                                          6%                    8%

    Non-GAAP
     operating
     margin as a
     percentage of
     revenues                                         18%                   15%


    GAAP tax on
     income                                         1,738                (3,501)

      Deferred tax
       assets
       adjustments,
       net                                          (633)                 5,046
                                                     ----                  -----

    Non-GAAP tax
     on income                                      1,105                  1,545
                                                    =====                  =====


    GAAP net income                                 9,644                 15,725

      Amortization of
       acquired
       intangible
       assets                                       2,545                  5,023

      Expense related
       to royalty
       buyout
       agreement with
       the Office of
        the Chief
        Scientist                                  12,875                      -

      Stock-based
       compensation
       expenses                                     2,735                  2,673

      Deferred tax
       assets
       adjustments,
       net                                            633                (5,046)

      Inventory
       write-off                                    1,889                      -

      Acquisition
       related
       expenses                                         -                 2,655

    Non-GAAP net
     income                                        30,321                 21,030
                                                   ======                 ======


    GAAP basic
     earnings per
     share                                           0.35                   0.58
                                                     ====                   ====

    Non-GAAP basic
     earnings per
     share                                           1.12                   0.77
                                                     ====                   ====


    GAAP diluted
     earnings per
     share                                           0.35                   0.57
                                                     ====                   ====

    Non-GAAP
     diluted
     earnings per
     share                                           1.10                   0.76
                                                     ====                   ====


    Shares used for calculation of earnings
     per share:

      Basic                                        27,175                 27,185
                                                   ======                 ======

      Diluted                                      27,503                 27,510
                                                   ======                 ======


    Company Contact:                    Investor Relations Contacts:

    Dror David, Chief Financial Officer Hayden/ MS-IR LLC

    Nova Measuring Instruments Ltd.     Miri Segal

    Tel: +972-73-229-5760               Tel: +917-607-8654

    E-mail: info@novameasuring.com      E-mail: msegal@ms-ir.com
    ------------------------------

    www.novameasuring.com               Or

                                        Brett Maas


                                        Tel: +646-536-7331

                                        E-mail: brett@haydenir.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nova-reports-record-fourth-quarter-and-full-year-2016-results-300406899.html

SOURCE Nova Measuring Instruments Ltd